We Empower Extraordinary
A passion for developing medicines for patients with hereditary angioedema (HAE) and other rare diseases
We are BioCryst.
A different kind of biotech company. A different kind of biotech company. A global company with over three decades of experience in drug discovery, development, and commercialization guided by our passion for not settling for “ordinary” in our quest to develop novel medicines. We listen. We understand. We know that little things can make a big difference to patients.
We aim to deliver extraordinary first-in-class or best-in-class oral small-molecule and protein therapeutics. It’s what sets BioCryst apart – and what we strive to achieve. Our transparent and supportive culture transforms employees into owners, converts challenges into resilience, and empowers people to achieve beyond what they think is possible. Let’s connect >>
WORKING WITH US
Passionate. Smart. Motivated. We’re all these qualities – but most importantly, we’re committed to making a difference in the lives of those living with rare diseases. If you’re someone who turns challenges into triumphs and aims to achieve beyond what you think is possible, we’re waiting for you.
OUR MEDICINES
Our focus is on breaking new ground in challenging rare disease categories. Using a novel, structure-guided approach, we blend traditional biology and medicinal chemistry with an array of advanced technologies with the goal of delivering first-in-class or best-in-class oral small-molecule and protein therapeutics to patients.
ABOUT US
Founded in 1986 out of the labs of the University of Alabama at Birmingham, BioCryst is one of the oldest independent, global biotechnology companies in operation. We have been guided by our commitment to never settle for ordinary in our quest to deliver novel medicines, and we continue to grow our presence around the globe to make “extraordinary” a reality for as many people as possible.